Showing results (151-160 of 199) with videos related to
Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2008
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiformeDavid A Reardon, Karen L Fink, Tom Mikkelsen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2016
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA Methyltransferase Biomarker AnalysesTimothy Cloughesy, Gaetano Finocchiaro, Cristóbal Belda-Iniesta, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 29, 2004
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-Attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant settingE Antonio Chiocca, Khalid M Abbed, Stephen Tatter, et al.Frontiers in Neuroinformatics|June 5, 2023
FAIR in action: Brain-CODE - A neuroscience data sharing platform to accelerate brain researchBrendan Behan, Francis Jeanson, Heena Cheema, et al.Journal of Neuro-Oncology|December 4, 2009
The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineTom Mikkelsen, Nina A Paleologos, Paula D Robinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2013
Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastomaTracy T Batchelor, Paul Mulholland, Bart Neyns, et al.Journal of Neuro-Oncology|December 4, 2009
The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guidelineTimothy C Ryken, Michael McDermott, Paula D Robinson, et al.Journal of Neuro-Oncology|December 5, 2009
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineMark E Linskey, David W Andrews, Anthony L Asher, et al.Journal of Neuro-Oncology|December 5, 2009
The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guidelineSteven N Kalkanis, Douglas Kondziolka, Laurie E Gaspar, et al.Journal of Neuroradiology = Journal De Neuroradiologie|July 7, 2014
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patientsManal Nicolasjilwan, Ying Hu, Chunhua Yan, et al.Pageof 20